Rachna Kataria, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 9 | 2023 | 10896 | 0.610 |
Why?
|
| Glutamate Decarboxylase | 1 | 2017 | 246 | 0.540 |
Why?
|
| Cerebellar Ataxia | 1 | 2017 | 145 | 0.520 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 2074 | 0.470 |
Why?
|
| Staphylococcus | 1 | 2013 | 155 | 0.450 |
Why?
|
| Pancytopenia | 1 | 2013 | 104 | 0.430 |
Why?
|
| Shock, Cardiogenic | 5 | 2023 | 688 | 0.420 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 1421 | 0.410 |
Why?
|
| Heart-Assist Devices | 2 | 2019 | 1195 | 0.400 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2019 | 1131 | 0.390 |
Why?
|
| Antibodies | 1 | 2017 | 2459 | 0.320 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11708 | 0.300 |
Why?
|
| Hospital Mortality | 7 | 2023 | 5316 | 0.260 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1400 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3338 | 0.210 |
Why?
|
| Hepatitis C Antibodies | 1 | 2019 | 145 | 0.170 |
Why?
|
| Angiodysplasia | 1 | 2019 | 23 | 0.160 |
Why?
|
| Angiopoietin-2 | 1 | 2019 | 172 | 0.150 |
Why?
|
| Parotitis | 1 | 2017 | 29 | 0.150 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2017 | 23 | 0.150 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2017 | 33 | 0.150 |
Why?
|
| Goals | 1 | 2022 | 708 | 0.150 |
Why?
|
| Thrombin | 1 | 2019 | 598 | 0.140 |
Why?
|
| Angioedema | 1 | 2017 | 187 | 0.130 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2016 | 132 | 0.130 |
Why?
|
| Aftercare | 1 | 2021 | 870 | 0.130 |
Why?
|
| Schizophrenia, Childhood | 1 | 2014 | 6 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 3070 | 0.120 |
Why?
|
| Coagulase | 1 | 2013 | 54 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2020 | 851 | 0.110 |
Why?
|
| Myocardial Revascularization | 1 | 2017 | 841 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2022 | 1470 | 0.110 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 3660 | 0.110 |
Why?
|
| Cardiology | 1 | 2023 | 1668 | 0.100 |
Why?
|
| Stroke Volume | 2 | 2022 | 5002 | 0.100 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 833 | 0.090 |
Why?
|
| Clozapine | 1 | 2014 | 498 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2016 | 899 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 63042 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2017 | 1002 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2023 | 3113 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2021 | 3317 | 0.080 |
Why?
|
| Hepatitis C | 1 | 2019 | 1591 | 0.080 |
Why?
|
| HIV Infections | 1 | 2013 | 16715 | 0.070 |
Why?
|
| Humans | 21 | 2023 | 743811 | 0.070 |
Why?
|
| Fever | 1 | 2014 | 1616 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4326 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3255 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 2104 | 0.060 |
Why?
|
| Antipsychotic Agents | 2 | 2014 | 3057 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 1 | 2013 | 1714 | 0.060 |
Why?
|
| Bed Occupancy | 1 | 2022 | 41 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5752 | 0.050 |
Why?
|
| Angiotensins | 1 | 2022 | 151 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8385 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20948 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7270 | 0.040 |
Why?
|
| Catheters | 1 | 2023 | 424 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2014 | 3044 | 0.040 |
Why?
|
| Sepsis | 1 | 2013 | 2593 | 0.040 |
Why?
|
| Female | 9 | 2023 | 380020 | 0.040 |
Why?
|
| Hospitals | 2 | 2022 | 3953 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15067 | 0.040 |
Why?
|
| New York | 1 | 2020 | 885 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2019 | 980 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 397 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2014 | 6865 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 7172 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 1077 | 0.030 |
Why?
|
| Angioplasty | 1 | 2017 | 364 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 1911 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2954 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2014 | 107 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 362 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 13869 | 0.030 |
Why?
|
| Male | 8 | 2023 | 349776 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 56392 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2023 | 2241 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 503 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2016 | 798 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 247 | 0.030 |
Why?
|
| Adolescent | 3 | 2016 | 85729 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2023 | 4576 | 0.030 |
Why?
|
| Prognosis | 2 | 2022 | 29052 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2023 | 23327 | 0.020 |
Why?
|
| Inpatients | 1 | 2022 | 2515 | 0.020 |
Why?
|
| Time Factors | 2 | 2023 | 40038 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77410 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2022 | 3679 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3580 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3527 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6750 | 0.020 |
Why?
|
| Aged | 3 | 2023 | 163178 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4152 | 0.020 |
Why?
|
| Risk Factors | 2 | 2022 | 72252 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 6030 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10259 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2017 | 2337 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 213241 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13980 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12788 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 9944 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13404 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 213889 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 40545 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16361 | 0.010 |
Why?
|
| Child | 2 | 2014 | 77637 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57744 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20121 | 0.010 |
Why?
|
| United States | 1 | 2014 | 69859 | 0.000 |
Why?
|